Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding novel ways to treat immune disorders and blood diseases, and developing new animal models for heart failure, diabetes and neurodegenerative diseases. The grants, …

Call them recreational athletes. Couch-to-5K joggers. Weekend warriors. Whichever name you use, they’re the ones who wait all week to hit the soccer field, basketball court or running trail on Saturday morning. They’re up at 5 a.m. for a long run before work or playing softball until the lights switch off at night. They might not …

The USC Epstein Family Center for Sports Medicine at Keck Medicine of USC, which specializes in treating sports-related and recreational injuries affecting the shoulder, knee, hip and elbow, recently announced the appointment of Frank Petrigliano, MD, as the chief of the center and head team physician for the Los Angeles Kings hockey team. He also …

“The field of stem cell biology is one of our great convergence opportunities,” said USC Provost Michael Quick, addressing an audience of biologists, chemists, physicists, engineers, clinicians and many others. This diverse group came together for the Interdisciplinary Stem Cell Symposium, hosted by USC Stem Cell and the USC Medicine, Engineering, Science and Humanities (MESH) …

Researchers and clinicians at the Keck School of Medicine of USC’s Department of Orthopaedic Surgery will advance their pioneering work on treatments and techniques to prevent and heal sports-related injuries thanks to a new $10 million gift.

If you lose a limb, it’s lost for life. If you damage a kidney, you won’t grow a new one. And if you have a heart attack, the scars are there to stay. But regenerative medicine is poised to change all of this. Building new tissue is within sight, and USC scientists are among the …

This year’s Broad Clinical Research Fellows will apply stem cell-based approaches to two prevalent problems: non-healing bone injuries, which affect 5 million Americans each year; and neuroblastoma, which is the most common solid tumor in children.

Jay R. Lieberman, chair and professor of orthopedic surgery at the Keck School of Medicine of the University of Southern California has received a five-year, $2.2 million grant from the National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases to research gene therapy to enhance repair of extensive bone injuries. Examples …

As chair of the Department of Orthopaedic Surgery at the Keck School of Medicine of USC, Jay R. Lieberman regularly sees patients with bone defects too severe to heal. This unmet clinical need inspired him to team up with two stem cell biologists, Gage Crump and Francesca Mariani, to find new solutions.

The Keck School of Medicine of the University of Southern California (USC) is one of four institutions to receive a multi-million dollar grant from the California Institute for Regenerative Medicine (CIRM) for translational research projects. The $2.5 million grant will support potential osteoarthritis therapies that could significantly impact standards of care for the disease. Arthritis …

The second cohort of Broad Clinical Research Fellows is making strides towards finding stem cell-based therapies for lymphedema in cancer patients, large bone fractures and short bowel syndrome.

Jay R. Lieberman, a principal investigator with USC Stem Cell, is the new president of the American Association of Hip and Knee Surgeons (AAHKS). He is professor and chair of the Department of Orthopaedic Surgery and director of the Institute of Orthopaedics at the Keck School of Medicine of USC and an internationally renowned total …

It wasn’t the pristine 27-hole course that drew more than 120 stem cell researchers from USC and beyond to the Desert Princess Golf Resort near Palm Springs. It was the sixth annual retreat for the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, which took place on October 20­ …

Three newly assembled disease teams within USC Stem Cell will take the early steps this year that might lead to future stem-cell based therapies for certain forms of deafness, bone defects and pediatric leukemia. The teams are winners of USC’s Regenerative Medicine Initiative (RMI), a university-wide program kick-started by $1.2 million in funding from Carmen …